BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Chen HY, Yu L, Tang BZ, Huang JH. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(7): 1112-1119 [PMID: 18286696 DOI: 10.3748/wjg.14.1112]
URL: https://www.wjgnet.com/1007-9327/full/v14/i7/1112.htm
Number Citing Articles
1
Y. Shi, Y. Lan, F. Cao, Y. Teng, L. Li, F. Wang, J. Li, J. Zhou, Y. Li. Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients Journal of Viral Hepatitis 2014; 21(7) doi: 10.1111/jvh.12236
2
Mingtao Quan, Lezhi Li, Xiaoli Yuan, Zhixia Jiang, Xuyao Wang, Hualian Wu, Xiaojuan Li. Influence of multiple factors on the incidence of occupational blood and body fluid exposures in health care workers in Guizhou, China: A structural equation modeling approachAmerican Journal of Infection Control 2015; 43(11): e73 doi: 10.1016/j.ajic.2015.07.014
3
Hyosun Cho, Hyojeung Kang, Hwan Lee, Chang Kim. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral HepatitisInternational Journal of Molecular Sciences 2017; 18(7): 1517 doi: 10.3390/ijms18071517
4
L. Boglione, A. D'Avolio, G. Cariti, M. G. Milia, M. Simiele, A. De Nicolò, V. Ghisetti, G. Di Perri. Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypesJournal of Viral Hepatitis 2013; 20(4): e11 doi: 10.1111/jvh.12018
5
R. S. Pandey, V. K. Dixit. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis BJournal of Drug Targeting 2010; 18(4): 282 doi: 10.3109/10611860903450015
6
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis BWorld Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
7
Christian A. Engell, Vinh Philip Pham, Robert S. Holzman, Judith A. Aberg. Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsISRN Gastroenterology 2011; 2011: 1 doi: 10.5402/2011/405390
8
Apostolos Koffas, Manoj Kumar, Upkar S. Gill, Ankur Jindal, Patrick T. F. Kennedy, S. K. Sarin. Chronic hepatitis B: the demise of the ‘inactive carrier’ phaseHepatology International 2021; 15(2): 290 doi: 10.1007/s12072-021-10137-2
9
Ayaid Khadem Zgair, Jenan A. Ghafil, Razaq H E Al-Sayidi. Direct role of antibody-secreting B cells in the severity of chronic hepatitis BJournal of Medical Virology 2015; 87(3): 407 doi: 10.1002/jmv.24067
10
Nesa Shokoohifar, Salman Ahmady-Asbchin, Sima Besharat, Fatemeh Roudbari, Saeed Mohammadi, Taghi Amiriani, Behnaz Khodabakhshi, Alireza Norouzi, Iman Shahabinasab. The Impaired Balance of CD4+/CD8+ Ratio in Patients with Chronic Hepatitis BHepatitis Monthly 2020; 20(1) doi: 10.5812/hepatmon.96799
11
He Liu, Mei Li, Mingjuan Jin, Fangyuan Jing, Hui Wang, Kun Chen. Public awareness of three major infectious diseases in rural Zhejiang province, China: a cross-sectional studyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-192
12
Lucio Boglione, Jessica Cusato, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. The E genotype of hepatitis B: Clinical and virological characteristics, and response to interferonJournal of Infection 2014; 69(1): 81 doi: 10.1016/j.jinf.2014.02.018
13
Hongyan Wang, Di Wu, Xiaofeng Wang, Guang Chen, Yuanya Zhang, Weiming Yan, Xiaoping Luo, Meifang Han, Qin Ning. Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathwaysBiological Chemistry 2016; 397(11): 1173 doi: 10.1515/hsz-2015-0290
14
Sukriti Sukriti, Nirupma Trehan Pati, Sujoy Bose, Syed S. Hissar, Shiv Kumar Sarin. Impaired Antigen Processing and Presentation Machinery is Associated with Immunotolerant State in Chronic Hepatitis B Virus InfectionJournal of Clinical Immunology 2010; 30(3): 419 doi: 10.1007/s10875-010-9379-4